PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$1.44B
1-Year Return
6.39%
This Quarter Return
+2.37%
1 Year Return
+6.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.77B
AUM Growth
+$467M
(+36%)
Cap. Flow
+$446M
Cap. Flow
% of AUM
25.26%
Top 10 Holdings %
Top 10 Hldgs %
19.38%
Holding
1,826
New
503
Increased
291
Reduced
226
Closed
774
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$121M |
| 2 |
NVIDIA
NVDA
|
+$31.8M |
| 3 |
Cigna
CI
|
+$25.8M |
| 4 |
Lowe's Companies
LOW
|
+$25M |
| 5 |
Visa
V
|
+$24.1M |
Top Sells
| 1 |
American International
AIG
|
+$15.4M |
| 2 |
Advanced Micro Devices
AMD
|
+$15.3M |
| 3 |
Booking.com
BKNG
|
+$14.2M |
| 4 |
Merck
MRK
|
+$13.4M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$12.6M |
Sector Composition
| 1 | Technology | 18.25% |
| 2 | Healthcare | 14% |
| 3 | Consumer Discretionary | 13.5% |
| 4 | Financials | 11.82% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Scansource
SCSC
$994M
| $12K | ﹤0.01% |
+394
| New | +$12K |
|
|
DZSI
927
DELISTED
DZS Inc. Common Stock
DZSI
| $11.8K | ﹤0.01% |
+1,495
| New | +$11.8K |
|
|
ICVX
928
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $11.6K | ﹤0.01% |
+2,002
| New | +$11.6K |
|
929
Lantronix
LTRX
$179M
| $11.4K | ﹤0.01% |
+2,619
| New | +$11.4K |
|
930
ProQR Therapeutics
PRQR
$231M
| $11.2K | ﹤0.01% |
+5,252
| New | +$11.2K |
|
|
INZY
931
DELISTED
Inozyme Pharma
INZY
| $10.9K | ﹤0.01% |
+1,897
| New | +$10.9K |
|
932
Douglas Elliman
DOUG
$240M
| $10.6K | ﹤0.01% |
+3,571
| New | +$10.6K |
|
933
Peapack-Gladstone Financial
PGC
$520M
| $10.4K | ﹤0.01% |
350
+54
| +18% | +$1.6K |
|
934
CorMedix
CRMD
$977M
| $10.3K | ﹤0.01% |
+2,477
| New | +$10.3K |
|
935
Alphatec Holdings
ATEC
$2.31B
| $10.2K | ﹤0.01% |
656
-5,599
| -90% | -$87.3K |
|
936
Coherus Oncology, Inc. Common Stock
CHRS
$155M
| $9.96K | ﹤0.01% |
+1,456
| New | +$9.96K |
|
937
Pyxis Oncology
PYXS
$115M
| $9.81K | ﹤0.01% |
+2,447
| New | +$9.81K |
|
938
Ameriprise Financial
AMP
$47.2B
| $9.81K | ﹤0.01% |
32
-392
| -92% | -$120K |
|
939
Prelude Therapeutics
PRLD
$68.5M
| $9.58K | ﹤0.01% |
+1,680
| New | +$9.58K |
|
|
GTHX
940
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $9.3K | ﹤0.01% |
+3,471
| New | +$9.3K |
|
941
Sight Sciences
SGHT
$190M
| $9.27K | ﹤0.01% |
+1,061
| New | +$9.27K |
|
942
Udemy
UDMY
$1.11B
| $9.02K | ﹤0.01% |
1,021
-6,656
| -87% | -$58.8K |
|
943
LanzaTech
LNZA
$45.5M
| $8.93K | ﹤0.01% |
+23
| New | +$8.93K |
|
944
Advantage Solutions
ADV
$619M
| $8.89K | ﹤0.01% |
+5,625
| New | +$8.89K |
|
945
Microvast
MVST
$916M
| $8.83K | ﹤0.01% |
+7,122
| New | +$8.83K |
|
946
Eversource Energy
ES
$24.1B
| $8.77K | ﹤0.01% |
+112
| New | +$8.77K |
|
947
Mid-America Apartment Communities
MAA
$16.9B
| $8.68K | ﹤0.01% |
+57
| New | +$8.68K |
|
948
PDF Solutions
PDFS
$789M
| $8.4K | ﹤0.01% |
198
-1,261
| -86% | -$53.5K |
|
|
VRAY
949
DELISTED
ViewRay, Inc.
VRAY
| $7.97K | ﹤0.01% |
2,304
-2,443
| -51% | -$8.45K |
|
950
Vital Farms
VITL
$2.17B
| $7.54K | ﹤0.01% |
+493
| New | +$7.54K |
|